Publishing research using ab179813? Please let us know so that we can cite the reference in this datasheet.
ab179813 has been referenced in 5 publications.
- Xiang R et al. Circadian clock gene Per2 downregulation in non-small cell lung cancer is associated with tumour progression and metastasis. Oncol Rep 40:3040-3048 (2018). PubMed: 30226549
- Zhang Y et al. Dosing time dependent in vitro pharmacodynamics of Everolimus despite a defective circadian clock. Cell Cycle 17:33-42 (2018). PubMed: 29099263
- Jiang X et al. Neurodegeneration-associated FUS is a novel regulator of circadian gene expression. Transl Neurodegener 7:24 (2018). PubMed: 30338063
- Chen B et al. Per2 participates in AKT-mediated drug resistance in A549/DDP lung adenocarcinoma cells. Oncol Lett 13:423-428 (2017). PubMed: 28123577
- Muter J et al. The clock protein period 2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells. FASEB J 29:1603-14 (2015). WB . PubMed: 25573754